The intrinsically disordered protein α-synuclein (αS) is thought to play an important role in cellular membrane processes. Although in vitro experiments indicate that this initially disordered protein obtains structure upon membrane binding, NMR and EPR studies in cells could not single out any conformational subensemble. Here we microinjected small amounts of αS, labeled with a Förster resonance energy transfer (FRET) pair, into SH-SY5Y cells to investigate conformational changes upon membrane binding. Our FRET studies show a clear conformational difference between αS in the cytosol and when bound to small vesicles. The identification of these different conformational subensembles inside cells resolves the apparent contradiction between in vitro and in vivo experiments and shows that at least two different conformational subensembles of αS exist in cells. The existence of conformational subensembles supports the idea that αS can obtain different functions which can possibly be dynamically addressed with changing intracellular physicochemical conditions.
The intrinsically disordered protein α-synuclein (αS) is thought to play an important role in cellular membrane processes. Although in vitro experiments indicate that this initially disordered protein obtains structure upon membrane binding, NMR and EPR studies in cells could not single out any conformational subensemble. Here we microinjected small amounts of αS, labeled with a Förster resonance energy transfer (FRET) pair, into SH-SY5Y cells to investigate conformational changes upon membrane binding. Our FRET studies show a clear conformational difference between αS in the cytosol and when bound to small vesicles. The identification of these different conformational subensembles inside cells resolves the apparent contradiction between in vitro and in vivo experiments and shows that at least two different conformational subensembles of αS exist in cells. The existence of conformational subensembles supports the idea that αS can obtain different functions which can possibly be dynamically addressed with changing intracellular physicochemical conditions.
Alpha-synuclein (αS) is
an intrinsically disordered protein (IDP) of 140 amino acids that
is abundantly present in neurons. Its physiological functions are
not well-understood, but it has been suggested to act as an interaction
hub for different binding partners. Its aggregation is involved in
the death of neurons in degenerative disorders such as Parkinson’s
disease and Lewy body dementia.The term “intrinsically
disordered” implies a lack
of both secondary and tertiary structure. However, in solution, long-range
contacts between residues cause αS to adopt an ensemble of significantly
more compact structures.[1] In vitro experiments
show that αS can organize into different folds that depend on
binding partners.[2] αS has been reported
to preferentially bind metal cations in the C-terminal region with
residual structure[3] and to associate with
several cytoplasmic proteins.[4−6] The best-characterized αS
fold is the membrane-bound α-helical conformation.[7,8] αS binds anionic lipid bilayers and the membrane of small
unilamelar vesicles of zwitterionic lipids in the liquid-ordered and
gel phase.[9−11] Membrane binding is accompanied by folding of αS
into α-helices that are oriented parallel to the membrane surface.[12−14] The membrane-bound conformation is thought to represent a functional
fold of the protein (reviewed by Snead and Eliezer[15]). By inserting amphipathic α-helices into the membranes
αS is thought to support curvature and (re)cluster vesicles.[16,17] Membrane-bound αS may additionally act as a nonclassical chaperone
in SNARE-mediated fusion processes.[18]However, in spite of the distinct conformations and conformational
diversity of αS observed in vitro, NMR and EPR studies seem
to indicate that in cells the disordered nature, observed for monomeric
αS in solution, is preserved.[19,20] Considering
the well-defined α-helical conformation of αS on membranes
in in vitro experiments and the high number of αS molecules
associated with cellular vesicles,[21] it
seems unlikely that all of the αS proteins retain a disordered
conformation inside cells. This controversy is a subject of intense
discussion in the current literature, as reviewed by Pauwels et al.[22] Here we set out to resolve this contradiction
and turned to imaging Förster resonance energy transfer (FRET)
to discriminate distinctly different conformational ensembles inside
cells.In agreement with the literature on the subcellular distribution
of αS in primary neurons that overexpress the protein, immuno-stained
images of primary rat neurons show endogenous αS in two distinct
localization patterns (Figure A,B).[23,24] Cytosolic endogenous αS
is visible as a diffuse background while the membrane-bound form of
the protein appears as distinct high-intensity puncta. To investigate
possible differences of the protein conformation between the protein
in the cytosol and the puncta we chose to microinject small amounts
of fluorescently labeled αS into SH-SY5Y cells, a well-established
neuronal cell model.[25] We observe the same
αS distribution of puncta and diffuse background in cells injected
with fluorescently labeled αS as in primary neurons (Figure C).
Figure 1
Localization of αS
in cells. (A) Confocal microscopy image
of rat primary neurons immuno-stained for αS (red), actin filaments
(green), and nuclei (blue) (scale bar is 10 μm). (B) In the
αS fluorescence from image A, here shown in a separate image,
the presence of both a diffuse background fluorescence and distinct
puncta is clearly visible. (C) Confocal microscopy image of a single
SH-SY5Y cell that was microinjected with αS-AF488. The αS
localization pattern is the same as that of primary neurons. The αS
is visible as a diffuse background and distinct high-intensity puncta
(scale bar is 5 μm).
Localization of αS
in cells. (A) Confocal microscopy image
of rat primary neurons immuno-stained for αS (red), actin filaments
(green), and nuclei (blue) (scale bar is 10 μm). (B) In the
αS fluorescence from image A, here shown in a separate image,
the presence of both a diffuse background fluorescence and distinct
puncta is clearly visible. (C) Confocal microscopy image of a single
SH-SY5Y cell that was microinjected with αS-AF488. The αS
localization pattern is the same as that of primary neurons. The αS
is visible as a diffuse background and distinct high-intensity puncta
(scale bar is 5 μm).After we confirmed that the puncta in the images indeed represent
αS on vesicles, using the method reported in ref (21) (Figure ), an αS FRET probe designed to identify
the membrane-bound α-helical conformation was introduced. In
vitro experiments have shown that αS binds lipid vesicle membranes
and micelles by organizing into an amphipathic α-helix.[10] This membrane-bound structure consists of two
α-helical segments comprising residues 3–37 and 45–92,
joined by a flexible linker.[12,13,26,27] To discriminate between the membrane-bound
α-helical and unstructured form of αS using changes in
FRET efficiency, the distance between the labeled residues has to
be markedly different in both forms. A maximum distance difference
is achieved by labeling at amino acid positions 9 and 69 (Figure A). In the antiparallel
α-helical form these residues are very close and thus show high
FRET, while in the unstructured form the average distance between
the residues is larger, resulting in lower FRET. Previous in vitro
experiments confirmed the ability of this probe to discriminate between
the membrane-bound and unstructured form of αS.[8]
Figure 2
Membrane-bound αS. To confirm that the distinct puncta in
the cells represent the vesicle-bound αS population, colocalization
with the membrane marker WGA-AF647 was studied. (A) Confocal fluorescence
image of SH-SY5Y cells microinjected with αS-AF488 (green) and
stained with WGA-AF647 (red). Independent excitation and detection
of the injected αS-AF488 (excitation 485 nm, detection 550/88
nm) and WGA-AF647 (excitation 640 nm, detection >665 nm) resulted
in moderate colocalization. However, the two dyes form an efficient
FRET pair, and this may render a fraction of the αS-AF488 invisible.
(B) Scatter plots of the WGA-AF647 fluorescence intensity versus αS-AF488
fluorescence intensity. Photobleaching of WGA-AF647 dequenched the
emission of αS-AF488, confirming the formation of a FRET pair
and thus the nanometer proximity of the two dyes. The dequenching
of the αS-AF488 fluorescence is visible as a shift of the intensity
distribution. The original distribution presented in green changes
upon bleaching to the distribution presented in orange. Data points
were obtained per pixel. (C) Colocalization image obtained by combining
the image of the initial WGA-AF647 fluorescence with the image of
the αS-AF488 fluorescence after dequenching. Colocalization
of αS-AF488 with the membrane is visible in yellow. In both
images the position of the nucleus is indicated with a blue transparent
oval; the scale bar is 5 μm.
Figure 3
(A) Schematic of the antiparallel helices (left) and a representation
of a disordered conformation of the FRET labeled αS. Differences
in distance between the red and green emitting fluorophores give different
FRET, here in the cartoon depicted by different relative sizes of
the donor and acceptor emission halos. (B) Composite donor and acceptor
fluorescence image of a single cell microinjected with the FRET-labeled
αS. Regions of low FRET (green) and high FRET (yellow-red) can
be discriminated. The position of the nucleus is indicated with a
transparent blue oval (scale bar is 5 μm). (C) Histogram of
the FRET index for αS in the cytoplasm (green) and on vesicles
(red). (D) Cumulative probability histogram of the FRET index for
αS in the cytoplasm (dotted green), on fibrils (dot-dashed blue),
and on vesicles (dashed red). The autofluorescence index of unlabeled
cells is indicated in solid black.
Membrane-bound αS. To confirm that the distinct puncta in
the cells represent the vesicle-bound αS population, colocalization
with the membrane marker WGA-AF647 was studied. (A) Confocal fluorescence
image of SH-SY5Y cells microinjected with αS-AF488 (green) and
stained with WGA-AF647 (red). Independent excitation and detection
of the injected αS-AF488 (excitation 485 nm, detection 550/88
nm) and WGA-AF647 (excitation 640 nm, detection >665 nm) resulted
in moderate colocalization. However, the two dyes form an efficient
FRET pair, and this may render a fraction of the αS-AF488 invisible.
(B) Scatter plots of the WGA-AF647 fluorescence intensity versus αS-AF488
fluorescence intensity. Photobleaching of WGA-AF647 dequenched the
emission of αS-AF488, confirming the formation of a FRET pair
and thus the nanometer proximity of the two dyes. The dequenching
of the αS-AF488 fluorescence is visible as a shift of the intensity
distribution. The original distribution presented in green changes
upon bleaching to the distribution presented in orange. Data points
were obtained per pixel. (C) Colocalization image obtained by combining
the image of the initial WGA-AF647 fluorescence with the image of
the αS-AF488 fluorescence after dequenching. Colocalization
of αS-AF488 with the membrane is visible in yellow. In both
images the position of the nucleus is indicated with a blue transparent
oval; the scale bar is 5 μm.(A) Schematic of the antiparallel helices (left) and a representation
of a disordered conformation of the FRET labeled αS. Differences
in distance between the red and green emitting fluorophores give different
FRET, here in the cartoon depicted by different relative sizes of
the donor and acceptor emission halos. (B) Composite donor and acceptor
fluorescence image of a single cell microinjected with the FRET-labeled
αS. Regions of low FRET (green) and high FRET (yellow-red) can
be discriminated. The position of the nucleus is indicated with a
transparent blue oval (scale bar is 5 μm). (C) Histogram of
the FRET index for αS in the cytoplasm (green) and on vesicles
(red). (D) Cumulative probability histogram of the FRET index for
αS in the cytoplasm (dotted green), on fibrils (dot-dashed blue),
and on vesicles (dashed red). The autofluorescence index of unlabeled
cells is indicated in solid black.Cells microinjected with αS, labeled with the AF488
FRET
donor and AF568 FRET acceptor, show clear differences in FRET between
different cellular structures or compartments (Figure B). In the composite image of the donor and
acceptor emission intensity, low FRET is visible in green. With increasing
FRET, the color in the composite image changes to yellow and red.
The cytoplasm of the cells is visible in green, which represents low
FRET; thus, the cytoplasm contains αS in unstructured from.
In the cytoplasm, yellow and red puncta can be observed, originating
from increased FRET. Clearly at least two distinctly different αS
conformations are present in the cell. Because we[21] and others[28] confirmed that
the puncta represent αS on small vesicles (Figure ), we can even go one step
further and conclude that the increased FRET in the puncta results
from the membrane-bound α-helical conformation of αS.For a more in-depth analysis, beyond single images, the FRET data
has to be quantified. To quantify, the intensities in both the FRET
donor (green) and acceptor (red) channel need to be related. However,
the signal in both of these channels is a combination of the FRET
signal and the cell’s autofluorescence. The autofluorescence
of the SH-SY5Y cells, with excitation at 485 nm, is not constant but
varies both in and between cells. The ratio between the autofluorescence
in the red and green channel, or autofluorescence index, is distributed
as shown in the cumulative histogram (Figure D). The distribution of the autofluorescence
index prevents the quantification of the data from the FRET images
in terms of a FRET efficiency. Therefore, the data was collected in
FRET index histograms for αS in the cytoplasm and on vesicles.
The FRET index is given by the ratio of the acceptor emission intensity
over the donor emission intensity. The FRET index will be low for
low FRET and high for high FRET.For both the membrane-bound
αS and αS in the cytoplasm,
the FRET index is distributed. For αS in the cytoplasm, the
peak FRET index is found at 0.22 while for αS on vesicles a
distinctly different peak FRET index of 0.45 is observed (Figure C). The shift to
higher FRET indices for the vesicle-bound αS is even more clearly
visible in the cumulative histogram (Figure D). The FRET index histogram of cytoplasmic
αS is narrower than that of membrane-bound αS. This narrow
distribution may be a result of compaction of the protein in the crowded
environment of the cytoplasm as was observed in in-cell NMR experiments.[20] The broader FRET index distribution of vesicle-bound
αS might be a result of the flexibility of the linker connecting
the two α-helical regions of membrane-bound αS, resulting
in a distribution of distances between the FRET pairs.[26,27,29] Additionally, in imaging small
vesicles, below the optical resolution, the sampled volume will always
also contain cytoplasm. This last factor together with the cellular
autofluorescence index, partly overlapping with the FRET signal, prevents
direct translation into a FRET efficiency. Hence these in vivo measurements
cannot be directly compared with FRET studies on in vitro model systems.
Control experiments in which a mixture of αS-AF488 and αS-568
was injected into the cells show that the observed high FRET on vesicles
does not result from intermolecular FRET due to crowding of the labeled
protein on the membrane surface or intermolecular interactions (Supporting Information, Figure S1).To
highlight the ability of our FRET probe to discriminate different
αS conformations we included data on αS fibrils in the
cumulative probability histogram (Figure D). The FRET index of the fibrils is rather
narrow and peaks at 0.27. The different FRET index peak value and
shape of the histogram indicate that a third conformational subensemble
of the protein can be discriminated using these labeling positions
and that the microinjected αS did not aggregate into amyloid
fibrils in the cells.In contrast to what has been previously
reported, our data shows
that the disordered nature of monomeric αS is not preserved
in cells. In vivo NMR and EPR studies may have overlooked the membrane-bound
conformation. The membrane-bound form of αS has been reported
to be only a small fraction of the total αS in the brain.[30] The NMR study already indicated that it may
not be possible to detect and discriminate lowly populated αS
states with this bulk method.[20] In the
NMR experiment, the αS concentration increases to tens of micromolars
which may saturate membrane binding sites, resulting in an additional
accumulation of unstructured αS in the cytoplasm. This excess
of unstructured cytoplasmic αS may mask the presence of the
membrane-bound population. The EPR studies were conducted on stage
V/VI Xenopus laevis oocytes at even
higher αS concentrations.[19] These
cells are in an inactive state which does not require much membrane
trafficking; trafficking vesicles will therefore be largely absent.
The cytoplasm mainly contains yolk granules, and the absence of membrane-bound
αS in these oocytes is therefore not surprising.The sensitivity
and ability to image and laterally resolve conformational
differences makes our method very well-suited to single out conformational
subensembles. Given the widely observed membrane-bound α-helical
conformation in in vitro experiments, the existence of this conformational
subensemble inside cells confirms our expectations. The used FRET
probe was designed to identify the membrane-bound α-helical
conformation of αS. Other probes can be designed to identify
subpopulations representing αS bound to metal cations,[3] synaptobrevin,[18] 14-3-3,[31] actin,[5] and other
proteins as reported in in vitro experiments. These multiple interactions
may represent different conformational subensembles that coexist in
a network of coupled binding equilibria. This distribution of αS
over these different subensembles is probably tightly balanced. The
sensitivity of these interactions to the changes in the intracellular
conditions may make αS a hub in interaction networks.
Authors: Jobin Varkey; Jose Mario Isas; Naoko Mizuno; Martin Borch Jensen; Vikram Kjøller Bhatia; Christine C Jao; Jitka Petrlova; John C Voss; Dimitrios G Stamou; Alasdair C Steven; Ralf Langen Journal: J Biol Chem Date: 2010-08-06 Impact factor: 5.157
Authors: Jacqueline Burré; Manu Sharma; Theodoros Tsetsenis; Vladimir Buchman; Mark R Etherton; Thomas C Südhof Journal: Science Date: 2010-08-26 Impact factor: 47.728
Authors: Mohammad A A Fakhree; Sjoerd A J Engelbertink; Kirsten A van Leijenhorst-Groener; Christian Blum; Mireille M A E Claessens Journal: Biomacromolecules Date: 2019-02-20 Impact factor: 6.988
Authors: Natasha S R Bidesi; Ida Vang Andersen; Albert D Windhorst; Vladimir Shalgunov; Matthias M Herth Journal: J Neurochem Date: 2021-10-03 Impact factor: 5.546
Authors: Velmarini Vasquez; Joy Mitra; Haibo Wang; Pavana M Hegde; K S Rao; Muralidhar L Hegde Journal: Prog Neurobiol Date: 2019-12-18 Impact factor: 11.685
Authors: Justine Lempart; Eric Tse; James A Lauer; Magdalena I Ivanova; Alexandra Sutter; Nicholas Yoo; Philipp Huettemann; Daniel Southworth; Ursula Jakob Journal: Life Sci Alliance Date: 2019-09-18
Authors: Anna I Sulatskaya; Natalia P Rodina; Maksim I Sulatsky; Olga I Povarova; Iuliia A Antifeeva; Irina M Kuznetsova; Konstantin K Turoverov Journal: Int J Mol Sci Date: 2018-08-23 Impact factor: 5.923